KAREN ADAMS: Open Payments
NPI 1417270315 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,980 in 104 payments from 21 companies in 2025. Trend: 2023 $1,839 · 2024 $2,229 · 2025 $1,980
Food & beverage: $1,980
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $212 |
| GENZYME CORPORATION | 9 | $210 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $207 |
| ABBVIE INC. | 14 | $192 |
| Regeneron Healthcare Solutions, Inc. | 7 | $152 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $143 |
| Almirall LLC | 6 | $115 |
| LEO Pharma Inc. | 5 | $109 |
| Organon LLC | 5 | $88 |
| Lilly USA, LLC | 4 | $85 |
Products named: DUPIXENT, Winlevi, COSENTYX, Seysara, SKYRIZI, SOFDRA, Zoryve, ADBRY.
Industry payments across TX — which companies pay providers there.
